Compare AbCellera Biologics Inc (ABCL) vs Tempus AI (TEM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Tempus AI — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Tempus AI trades at $56.89 (market cap $10.79B). The key difference: Tempus AI is far larger — about 4.6× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| ABCL | TEM | |
|---|---|---|
Market Cap | $2.35B | $10.79B |
Sector | Health | Broad Market / Factor |
52-Week High | $8.12 | $103.25 |
52-Week Low | $2.78 | $42.37 |
Enterprise Value | $1.99B | $11.47B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
